Lichen International Ltd (LICN) Stock Analysis

Verdict: AVOID

Collapsing fundamentals and a 90% weekly drawdown signal a distressed micro-cap in a liquidity spiral with no visible fundamental floor.

Investment score: 12/100

Analysis as of

Is Lichen International Ltd stock worth reviewing? The TradeMates thesis

Lichen International is exhibiting signs of fundamental and technical collapse. Revenue is down 41% YoY, and the company has swung from profitability to deep losses (-$22M). While the cash per share exceeds the current stock price, the negative FCF yield of -2921% suggests this value is being incinerated.

7-factor investment score

Lichen International Ltd opportunities and risks

What speaks for LICN

What speaks against LICN

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
LICNn/a0.0x2.5x37.3%-89.6%-2921.7%
ULNVn/a7320.4xn/a50.3%-8.3%-0.1%
EPOWn/a0.3xn/a-3.0%-12.1%-207.2%
SOSn/a0.0xn/a1.5%-63.1%-2129326.9%
Peer mediann/a0.3xn/a1.5%-12.1%-207.2%

Frequently asked questions about Lichen International Ltd (LICN)

Is LICN stock a good investment?

The TradeMates model rates Lichen International Ltd as AVOID with an investment score of 12/100. Lichen International is exhibiting signs of fundamental and technical collapse. Revenue is down 41% YoY, and the company has swung from profitability to deep losses (-$22M). While the cash per share exceeds the current stock price, the negative FCF yield of -2921% suggests this value is being incinerated. This is algorithmic model output, not personal investment advice.

Is LICN stock a buy?

The TradeMates model verdict for LICN is AVOID with an investment score of 12/100. Treat this as a model signal to review, not a personal buy recommendation.